Clinical Trials Browser

Phase 2 × NSCLC Harboring NRG1 Fusion × Afatinib × Clear all

NCT05588609 2025-09-18

Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers

Phase 2 Terminated

GenitourinaryThoracic

NSCLC Harboring NRG1 Fusion